This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardialinfarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
Our primary CVD outcome was defined by a combined end point that included either incident myocardialinfarction, stroke, or heart failure.Results:Using a discovery/validation approach, 42 proteins were associated with our primary composite end point occurring in 1163 subjects. Thirteen proteins were related to all 3 outcomes.
Further research and attention to this area are crucial for improving patient outcomes and guiding clinical interventions in this challenging condition.MethodsICD‐10‐CM codes were used to query the National Inpatient Sample (NIS) for patients with AIS between 2010 and 2019. Patients with AKI were on average older (63.29
Anyway, I was invited to write the article by Dr Eric Westman, who was the guest editor for this edition of ‘ Current Opinion in Endocrinology, Diabetes and Obesity.’ There are numerous other conditions leading to this kind of damage, which can trigger thrombus formation, causing strokes and myocardialinfarctions.
This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes. For example, the global spread of obesity, particularly among youth, has set the stage for a future pandemic of non-communicable diseases.
Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.
11, 2024 — In the first national estimate in two decades, researchers at the University of California-San Francisco (UCSF) report that 10.5 A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity.
The profound link between the heart and mind has been the subject of much research for some time, with newer studies reinforcing the existing evidence as well as offering deeper insights. As we step into American Heart Month, it becomes imperative to delve into the intricacies of this relationship and dissect the latest research findings.
11 — In the first national estimate in two decades, researchers at the University of California-San Francisco (UCSF) report that 10.5 A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity.
In a study published by the American Heart Association, “Sex and Age Differences in the Association of Depression With Obstructive Coronary Artery Disease and Adverse Cardiovascular Events,” researchers investigated 3,237 patients (35% women) undergoing coronary angiography to evaluate for coronary artery disease (CAD).
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardialinfarction (MI), stroke, and cardiovascular (CV) death.4 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11
EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardialinfarction (MI). STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. Here is our curated list of the top sessions.
Lifestyle Habits: Obesity, smoking, excessive alcohol consumption, and lack of exercise can all negatively impact sexual function. Risk Factors for ED: Heart disease, specifically coronary artery disease (CAD) and acute myocardialinfarction (AMI), is closely linked to male erectile dysfunction.
SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Read the published study. Access the full study. View the study. Watch AI-ECHO results.
BackgroundAlthough reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardialinfarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased.
BackgroundThe mortality of patients with acute myocardialinfarction (MI) raised rapidly in last decade and obesity are becoming the major cause to CAD progression, thus inducing heart failure preserved ejection fraction (HFpEF). Also, SASPs decreased in hypoxic fibroblasts after OGN knockdown.
42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Emerging Risk Factors: Non-traditional factors such as the microbiome, pollution, and somatic mutations are increasingly linked to “SMuRFless” myocardialinfarction (MI) cases. In the U.S.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content